A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure

Kidney International

Volumn 72, Issue 3, 2007, Pages 348-358

  Negishi, K ^a   Noiri, E ^a   Sugaya, T ^b   Li, S ^c   Megyesi, J ^c   Nagothu, K ^c   Portilla, D ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Strategic and Regulatory Affairs Consulting Department   (Japan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute renal failure; Cisplatin nephrotoxicity; Lipids

Indexed keywords

CISPLATIN; FATTY ACID BINDING PROTEIN; FIBRIC ACID DERIVATIVE; LIGAND; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DISEASE SEVERITY; HUMAN; KIDNEY PROXIMAL TUBULE; LABELING INDEX; MALE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TRANSGENIC MOUSE; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CISPLATIN; CREATININE; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PEROXISOME PROLIFERATORS; PEROXISOMES; PYRIMIDINES; RNA, MESSENGER;

EID: 34547404668     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002304     Document Type: Article

References (44)

1. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006; 47: 39-48.
2. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 2002; 59: 1096-1116.
3. Haunerland NH, Spener F. Fatty acid binding proteins - insights from genetic manipulations. Prog Lipid Res 2004; 43: 328-349.
4. Huang H, Starodub O, McIntosh A et al. Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor-α and enhances ligand distribution to nuclei of living cells. Biochemistry 2004; 43: 2484-2500.
5. Antonenkov VD, Sormunen RT, Ohlmeier S et al. Localization of a portion of the liver isoform of fatty acid-binding protein (L-FABP) to peroxisomes. Biochem J 2006; 394: 475-484.
6. Reddy JK. Peroxisome proliferators and peroxisome proliferators-activated receptor-α. Am J Pathol 2004; 164: 2305-2321.
7. Kaikaus RM, Chan WK, Ortiz de Montellano PR et al. Mechanisms of regulation of liver fatty acid-binding protein. Mol Cell Biochem 1993; 123: 93-100.
8. Simon TC, Roth KA, Gordon JI. Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J Biol Chem 1993; 268: 18345-18358.
9. Oyama Y, Takeda T, Hama H et al. Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 2005; 85: 522-531.
10. Maatman RGHJ, Van de Westerlo EMA, Van Kuppevelt THMSM et al. Molecular identification of the liver- and the heart-type fatty acid-biding proteins in human and rat kidney. Biochem J 1992; 288: 285-290.
11. Maatman RGHJ, Van Kuppevelt THMSM, Veerkamp JH. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J 1991; 273: 759-766.
12. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255.
13. Sugaya T, Noiri E, Yamamoto T et al. L-Type fatty acid-binding protein ameliorates renal ischemia reperfusion injury in human L-FABP transgenic mice. Nephrology 2005; 10(Suppl): A133.
14. Portilla D, Dai G, Peters JM et al. Etomoxir-induced PPARalpha modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 2000; 278: F667-F675.
15. Portilla D, Dai G, McClure T et al. Alterations of PPARalpha and its coactivator PGC-1 in CP-induced acute renal failure. Kidney Int 2002; 62: 1208-1218.
16. Portilla D. Energy metabolism and cytotoxicity. Semin Nephrol 2003; 23: 432-438.
17. Li S, Wu P, Yarlagadda P et al. PPARalpha ligand protects during CP-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am J Physiol Renal Physiol 2004; 286: F572-F580.
18. Li S, Bhatt R, Megyesi J et al. PPAR-alpha ligand ameliorates acute renal failure by reducing CP-induced increased expression of renal endonuclease G. Am J Physiol Renal Physiol 2004; 287: F990-F998.
19. Li S, Gokden N, Okusa MD et al. Anti-inflammatory effect of fibrate protects from CP-induced ARF. Am J Physiol Renal Physiol 2005; 289: F469-F480.
20. Nagothu KK, Bhatt R, Kaushal GP et al. Fibrate prevents CP-induced proximal tubule cell death. Kidney Int 2005; 68: 2680-2693.
21. Schonefeld M, Noble S, Bertorello AM et al. Hypoxia-induced amphiphiles inhibit renal NaK-ATPase. Kidney Int 1996; 49: 1289-1296.
22. Feldkamp T, Kribben A, Roeser NF et al. Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation. Am J Physiol Renal Physiol 2005; 290: F465-F477.
23. Portilla D, Li S, Nagothu KK et al. Metabolomic study of CP-induced nephrotoxicity. Kidney Int 2006; 69: 2194-2204.
24. Colton HM, Falls JG, Ni H et al. Visualization and quantitation of peroxisomes using fluorescent nanocrystals: treatment of rats and monkeys with fibrates and detection in the liver. Toxicol Sci 2004; 80: 183-192.
25. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255.
26. Gulati S, Singh AK, Irazu C et al. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. Arch Biochem Biophys 1992; 295: 90-100.
27. Klionsky DJ. The molecular machinery of autophagy: unanswered questions. J Cell Sci 2005; 118: 7-18.
28. Cuervo AM. Autophagy in neurons: it is not all about food. Trends Mol Med 2006; 12: 461-464.
29. Dunn WA, Cregg JM, Kiel J AKW et al. Pexophagy. The selective autophagy of peroxisomes. Autophagy 2005; 1: 75-83.
30. Berkenstam A, Ahlberg J, Glaumann H. Isolation and characterization of autophagic vacuoles from rat kidney cortex. Virchows Arch B Cell Pathol Incl Mol Pathol 1983; 44: 275-286.
31. Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochimica et Biophysica Acta 2006; 1763: 1755-1766.
32. Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006; 75: 295-332.
33. Rottensteiner H, Theodoulou FL. The ins and outs of peroxisomes: coordination of membrane transport and peroxisomal metabolism. Biochimica et Biophysica Acta 2006; 1763: 1527-1540.
34. Visser WF, van Roermund CWT, Ijlst L et al. Metabolite transport across the peroxisomal membrane. Biochem J 2007; 401: 365-375.
35. Wanders RJ, van Roermund CW, Visser WF et al. Peroxisomal fatty acid a and β-oxidation in health and disease: new insights. Adv Exp Med Biol 2003; 544: 293-302.
36. Ockner RK, Manning JA, Poppenhausen RB et al. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 1972; 177: 56-58.
37. Maatman RG, van den Westerlo EM, van Kuppevelt TH et al. Molecular identification of the liver and the heart-type fatty acid binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992; 15: 285-290.
38. Vancura A, Haldar D. Regulation of mitochondrial and microsomal phospholipid synthesis by liver fatty acid binding protein. J Biol Chem 1992; 267: 14353-14359.
39. Raza H, Pongubala JR, Sorof S. Specific high affinity binding of lipooxygenase metabolites of arachidonic acid by liver fatty acid-binding protein. Biochem Biophys Res Commun 1989; 161: 448-455.
40. Takikawa H, Kaplowitz N. Binding of bile acids, oleic acid, and organic anions by rat and human hepatic Z protein. Arch Biochem Biophys 1986; 251: 385-392.
41. Faber K, Hvidberg V, Moestrup SK et al. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol Endocrinol 2006; 20: 212-218.
42. Masson P, Ohlsson P, Bjorkhem I. Combined enzymic-Jaffe method for determination of creatinine in serum. Clin Chem 1981; 27: 18-21.
43. Kamijo A, Kimura K, Sugaya T et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004; 143: 23-30.
44. Kamijo-Ikemori A, Sugaya T, Obama A et al. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006; 169: 1107-1117.